If you have herpes and went looking for treatment options, you probably noticed something odd. Every pill your doctor can prescribe was approved in the 1980s or 1990s. There is no vaccine. There is no cure. And most people with the virus were never even diagnosed: in CDC survey data, about 8 in 10 Americans with HSV-2 had never been told by a doctor that they have it. That silence around the disease is part of why progress has been slow.
But the picture is changing, and 2026 is turning into a real inflection point. This guide walks through everything that is approved today, what researchers are testing right now, and why herpes drug development took this long.
Looking for treatment options for Herpes?
Browse open herpes clinical trials near you! We'll handle the follow-up.
What is approved today
Every core herpes medicine belongs to one drug family called nucleoside analogs. In plain terms, these drugs stop the virus from copying itself. They shorten outbreaks and make them come back less often, but they can't reach the virus once it hides in nerve cells. That's why none of them is a cure.
The main options are acyclovir (Zovirax), famciclovir (Famvir), and valacyclovir (Valtrex). Acyclovir is the original, approved by the FDA in 1982 as an ointment and 1985 as a pill, and it's still widely used today. Famciclovir, approved in 1994, works the same way. Valacyclovir, approved in 1995, gets converted into acyclovir by your body once you swallow it.
A few more options cover specific situations. Penciclovir cream (Denavir) is approved for cold sores, and docosanol cream (Abreva) is sold over the counter. For herpes infections of the eye, there are trifluridine drops (Viroptic) and ganciclovir gel (Zirgan). And for people with weakened immune systems whose virus stops responding to acyclovir, doctors turn to an older IV drug called foscarnet.
That's the full list. Valacyclovir arrived in 1995, and no genuinely new class of herpes drug has been approved since, about 30 years on the same mechanism.
What researchers are studying now
This is where it gets interesting. The first truly new class of herpes antivirals, called helicase primase inhibitors, is finally getting close to approval. These drugs block a different part of the virus than the old pills do, which matters most for people whose virus has stopped responding to acyclovir.
Pritelivir (made by AiCuris) is furthest along. In its main Phase 3 trial, called PRIOH-1, it worked better than the current backup treatments, including foscarnet, for patients with weakened immune systems whose herpes no longer responds to acyclovir. There's no single agreed-upon second choice treatment in this situation, so the trial compared pritelivir against whatever each doctor would normally reach for instead. In 2026, the FDA gave pritelivir's application priority review, and the company shared more Phase 3 data at two major medical conferences that same year. If it gets approved, it would be the first new type of herpes antiviral in about three decades.
Patients whose immune system cannot hold the virus down are also the focus of long running government research: the National Institute of Allergy and Infectious Diseases is enrolling 600 people in a study of severe viral infections and immune defects covering HSV alongside Epstein-Barr and varicella zoster, work aimed at understanding why some people get hit so much harder.
ABI-5366 and ABI-1179 (from Assembly Biosciences) are long-acting pills from this same new drug class, built for people with frequent genital herpes outbreaks. Long-acting means taking a pill once a week or even once a month instead of every day. Early results for ABI-5366 in August 2025 showed reduced shedding and lesions; by December, ABI-1179 showed similar results too. These are small, early studies, so think of them as a promising sign, not a proven treatment yet. But the idea itself matters: a daily pill for a lifelong virus is its own kind of burden, and a once-a-month option would change that even without changing how the drug works.
Vaccines are making a comeback too. After about a decade of quiet following some very public failures, mRNA vaccines for herpes are now in early trials. Early means just that, Phase 1, still years away from approval. But researchers have new tools this time that weren't around during the last attempt.
So how far away is an actual cure? Nobody really knows, and no serious researcher will give you a date. What we can say is that progress is finally moving again, and the next real milestone is a possible pritelivir approval, not a cure. A true cure would mean clearing the virus out of nerve cells completely, and nothing currently in late-stage trials does that yet.
Why herpes research takes this long
Three named problems slow this field down more than most.
The measurement problem. The standard way to prove a genital herpes drug works is the viral shedding rate. Participants collect their own genital swabs every single day, often for weeks, and labs check each swab for virus by PCR. It is objective and sensitive, but it asks a lot of volunteers. Recruiting people willing to do daily swabbing takes time, and every trial inherits that burden. Some of what researchers know about how the virus behaves between outbreaks comes from observational work rather than drug trials, like the 1,000 person natural history study that the National Institute of Allergy and Infectious Diseases runs on anogenital herpes and cold sores.
The failure history. Herpes vaccine development has burned sponsors before. The large Herpevac trial failed in 2010, and years later, in 2017, the promising GEN-003 program was shelved too, not because it failed, but because its maker pivoted to cancer vaccines instead. Investors and companies became cautious, and for years few dared to fund new attempts. The current mRNA wave is the first serious return. That gap explains something patients find baffling: how can a virus this common have no vaccine? It is not that nobody tried. The tries did not work, and the money went elsewhere for a decade.
The stigma problem. Herpes carries social stigma that most diseases do not. Many people research it anonymously and hesitate to walk into a clinic and identify themselves as a potential participant. That makes recruitment slower and quieter than the actual prevalence of the virus would suggest: about 1 in 8 Americans aged 14 to 49 carries HSV-2, yet trials for it fill more slowly than trials for conditions a fraction as common.
Does herpes affect more than skin?
For most otherwise healthy adults, herpes stays a skin and nerve condition. It is unpleasant, but it is not life threatening and does not shorten life expectancy. Still, the virus has documented links beyond sores that are worth knowing.
WHO reports that HSV-2 infection roughly triples the risk of acquiring HIV, which is one reason public health agencies care about herpes prevention. In rare cases the virus reaches the brain and causes encephalitis, which historically killed about 7 in 10 untreated patients and remains a medical emergency even with modern antivirals. And newborns infected at birth face severe disease: untreated disseminated neonatal herpes was fatal in most cases before IV acyclovir, which cut that mortality dramatically.
None of this is meant to alarm you. These outcomes are rare, and the common forms of herpes are manageable.
What is eye herpes?
The eye is the one common site people do not expect. HSV can infect the eye, and HSV keratitis, an infection of the cornea, is a leading infectious cause of corneal blindness worldwide according to WHO. It is also the one place with its own dedicated approved medicines: trifluridine drops and ganciclovir gel are both approved specifically for herpes infection of the eye. Eye symptoms are not something to wait out. Pain, redness, blurred vision or light sensitivity in one eye is a same-day call to an eye doctor, whether or not you know you have herpes.
Common myths worth clearing up
"Canker sores are herpes"
No. According to NIDCR, canker sores do not have a known cause and are not contagious. Cold sores are the ones caused by HSV, and unlike canker sores they do spread to other people.
"Some cold sores are herpes and some are not"
Also no. Cold sores, which doctors also call fever blisters, are caused by herpes simplex virus, usually HSV-1. There is no other kind. The two names describe the same thing, and the confusion is mostly because "cold sore" sounds harmless and "herpes" does not.
"HPV and herpes are the same thing"
Different viruses entirely. HPV is the human papillomavirus, HSV is the herpes simplex virus. They cause different conditions and are confused mostly because both spread through close contact.
"You can only pass herpes when you have sores"
This one causes real harm. The virus sheds from skin even when nothing is visible, a process called asymptomatic shedding, and this silent shedding drives much of transmission. It is also why shedding rate became the key measurement in trials.
The stages of a herpes outbreak
Herpes has no formal staging system the way some diseases do. But a typical outbreak follows five recognizable phases, and knowing them helps you talk to doctors and understand study requirements.
Prodrome. Tingling, itching or burning where sores are about to appear. Nothing visible yet. People who take antiviral pills episodically typically have a plan agreed with their doctor for exactly this moment, because that is when the medicines were studied being started.
Blisters. Small blisters form, filled with clear or straw colored fluid, usually on a red and swollen base. On a first oral infection they can appear on the lips, gums, the roof of the mouth and the tongue at once. Recurrences are more contained, typically a cluster on the lip edge or in one genital area. Care at this point is usually whatever plan you and your doctor already set.
Ulcers. Blisters break open into shallow, very painful sores. This is the most painful phase and usually the peak of contagiousness. Typical care focuses on comfort and keeping the area clean and dry, and clinicians commonly advise against picking at or covering sores in ways that keep them wet.
Crusting. Sores dry and scab over. Contagiousness is falling but not gone, since the virus also sheds without symptoms.
Healing. Skin closes up. In a first episode, sores crust and heal in about 7 to 14 days or more, and the whole episode can come with fever, body aches, swollen lymph nodes and a general sick feeling. Later outbreaks are usually shorter and milder. Between outbreaks, people with frequent recurrences sometimes take daily antivirals, an approach their doctor decides with them.
Clinical trials often ask how many outbreaks you get per year, and some ask you to log the phases as they happen. Your outbreak history is real data to a researcher.
Can you make a herpes outbreak heal faster?
The honest answer has two parts. First, the approved antivirals were studied precisely for this, shortening outbreaks and reducing how often they return, and how they are used in your case is a conversation with your doctor rather than something a guide should prescribe. Second, no supplement, cream or home remedy has been approved for it. The research record shows a ceiling: even the approved drugs shorten episodes rather than stopping them, which is exactly the limitation the new drug class is trying to push past.
How to find a herpes study
Right now the herpes pipeline needs volunteers more than it needs anything else. Every result described above, from pritelivir's Phase 3 to Assembly's shedding data, exists because people with herpes signed up and did the daily swabs.
AllClinicalTrials.com lists recruiting herpes studies across the United States right now, including NIAID's ongoing study of severe viral infections and immune defects in HSV, EBV, and VZV, a broader NIAID study covering anogenital herpes alongside other viral infections, and an observational study tracking symptomatic herpes in people living with HIV. You can filter by city and state, and read what each study involves before contacting anyone. The application takes about 5 minutes, and applying does not commit you to anything. A study team will walk you through informed consent before any decision is made.
Common questions
What is herpes, in simple terms? Herpes is an infection with herpes simplex virus. Two types exist: HSV-1 sits behind most cold sores, HSV-2 behind most cases below the waist. Once you catch it, the virus settles into nerve cells and stays for life, waking up now and then to cause sores. Plenty of people carry it with mild symptoms or none at all, which is why so many never learn they have it.
Is there a cure for herpes? No. Today's medicines control outbreaks but do not remove the virus from the body. Late stage trials are testing a new drug class, and vaccine candidates are in early trials, but no cure exists yet.
What is the viral shedding rate? It is the main efficacy measurement in genital herpes trials: the share of days the virus can be detected on daily self collected swabs. A drug that lowers shedding is reducing both outbreak risk and transmission risk, which is why trials track it so closely.
What does a first herpes outbreak look like? The first outbreak most often starts within 2 days to 2 weeks of catching the virus. Small, painful blisters show up first, filled with a clear or yellowish fluid, then break into shallow, very painful sores. The sores crust over and heal in 7 to 14 days or more. The first episode is usually the roughest: it can bring fever, muscle aches, swollen lymph nodes, and a general sick feeling. Later outbreaks tend to be shorter and less severe.
Can you get herpes on your tongue? Yes, mostly during a first infection. A first oral herpes infection can cause painful sores on the tongue, the gums, the roof of the mouth, and the lips all at once. When the virus comes back later, it usually shows up as a cold sore on the lip edge, not inside the mouth. Oral herpes returns about one to six times per year.
Can herpes kill you? For otherwise healthy adults, oral and genital herpes is not life threatening and does not shorten life expectancy. Rare exceptions exist, such as herpes infections in newborns and herpes encephalitis, so discuss any concerns with your doctor.
See herpes clinical trials recruiting now:
Browse open studies and check your eligibility on our herpes clinical trials page.